Physician

Malcolm A Smith, MD

According to 2025 Medicare claims, Malcolm Smith, MD (NPI: 1174525174) practices pulmonary disease in the Texarkana, TX-AR market, with the plurality of this provider's patient population coming from Bowie, TX. This provider's primary affiliated billing organization is COLLOM AND CARNEY CLINIC (NPI: 1083696801; TIN: 751151440) and primary practice location at 75503-2125. Smith is affiliated with the Prime Care Managers, LLC (ACO ID: A3280), participating under the MSSP model.

Smith's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,029 traditional Medicare patients, billed 4,531 HCPCS/CPT codes, and received $326,593 in Medicare payments. The top billing code was 95811 (Sleep study in sleep lab with continuous airway pressure (6 years or older)). Part D data shows 2,343 prescription claims across 321 beneficiaries totaling $1,709,943 in drug costs, led by Ofev (Nintedanib Esylate). DME data shows 2,169 claims. Open Payments data shows 95 records totaling $2,409. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $388,911 to $1,709,943. For DME billing, reported payments did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,883	7,752	$443,198
2016	3,128	11,619	$454,165
2017	3,204	9,061	$442,043
2018	2,806	6,756	$421,439
2019	2,979	8,373	$477,953
2020	2,507	6,194	$350,598
2021	2,784	6,511	$418,249
2022	2,759	5,791	$353,923
2023	2,618	5,336	$340,419
2024	2,029	4,531	$326,593

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	315	2,047	$388,911
2016	314	1,813	$372,990
2017	351	1,979	$590,699
2018	337	1,798	$545,749
2019	313	1,682	$615,791
2020	303	1,777	$940,161
2021	322	1,975	$1,123,713
2022	321	1,916	$1,194,572
2023	341	2,281	$1,266,143
2024	321	2,343	$1,709,943

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	1,071	3,805	$247,365
2016	952	3,582	$161,020
2017	938	3,488	$133,313
2018	795	2,770	$109,745
2019	727	2,577	$125,591
2020	650	2,668	$143,772
2021	552	2,335	$149,126
2022	447	2,119	$139,265
2023	535	2,284	$153,470
2024	507	2,169	$167,525

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95811	Sleep study in sleep lab with continuous airway pressure (6 years or older)	272	280	$373
94729	Test to examine how well the lungs exchange gases	315	318	$38
94726	Test to determine lung volumes using sensors	317	320	$37
94060	Test to measure expiratory airflow and volume changes before and after medication administration	241	244	$25
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	822	994	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ofev	Nintedanib Esylate	69	2,070	$917,388
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	226	9,420	$195,147
Opsumit	Macitentan	11	330	$138,890
Pirfenidone	Pirfenidone	13	390	$116,149
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	50	2,100	$42,237

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	40	349	$33,165
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	32	$25,698
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	20	$20,153
E0483	High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, each	Y	N/R	14	$12,510
E1392	Portable oxygen concentrator, rental	Y	27	229	$8,240

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	95	$2,409	United Therapeutics Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Malcolm A. Smith, MD?

Tedicare shows public-source Medicare data for Malcolm A. Smith, MD (NPI 1174525174), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Malcolm A. Smith, MD have ACO affiliation data?

Malcolm A. Smith, MD is shown with ACO affiliation data for Prime Care Managers, LLC (MSSP, ACO ID A3280).

What billing organization is linked to Malcolm A. Smith, MD?

Malcolm A. Smith, MD is linked to COLLOM AND CARNEY CLINIC (billing NPI 1083696801) in the available physician profile data.

Does Malcolm A. Smith, MD have Open Payments data?

Malcolm A. Smith, MD has 95 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.